Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
Liu D, Wong CC, Fu L, Chen H, Zhao L, Li C, Zhou Y, Zhang Y, Xu W, Yang Y, Wu B, Cheng G, Lai PB, Wong N, Sung JJY, Yu J.
Liu D, et al. Among authors: xu w.
Sci Transl Med. 2018 Apr 18;10(437):eaap9840. doi: 10.1126/scitranslmed.aap9840.
Sci Transl Med. 2018.
PMID: 29669855